Abstract
Objective
To explore the effects of exosomes loaded with circular RNA PARD3 on EBV-miR-BART4-induced stemness and resistance of cisplatin in nasopharyngeal carcinoma side population (NPC-SP) cells through the miR-579-3p/SIRT1/SSRP1 axis.
Methods
Sixty-five cancer tissues and 65 noncancerous tissues were collected from NPC patients or patients with rhinitis. The expressions of circPARD3, miR-579-3p, SIRT1, and SSRP1 were detected by qRT-PCR, western blot, or immunohistochemistry. In vivo tumor formation assay was performed in nude mice. Immunofluorescence and qRT-PCR were conducted for the determination of CD44 and CD133 expressions, and flow cytometry combined with Hoechst 33,342 dye efflux for identifying SP cells, CCK-8 and EdU assays for cell proliferation, and Transwell assay for migration and invasion.
Results
CircPARD3, SIRT1, and SSRP1 were upregulated while miR-579-3p was downregulated in NPC tissues and cells. CircPARD3 was positively correlated with the expressions of SIRT1 and SSRP1, and miR-579-3p was negatively correlated with circPARD3, SIRT1, and SSRP1. Exosomes loaded with circPARD3 promoted EBV-miR-BART4-induced stemness and cisplatin resistance in NPC-SP cells, while miR-579-3p reversed the effect of exosomal circPARD3 on EBV-miR-BART4-induced stemness and cisplatin resistance in NPC-SP cells. Additionally, miR-579-3p suppressed EBV-miR-BART4-induced stemness and cisplatin resistance in NPC-SP cells by regulating SIRT1. SIRT1 upregulated SSRP1 expression by catalyzing H3K4 methylation and down-regulation of SSRP1 reversed the effect of SIRT1 on EBV-miR-BART4-induced stemness and cisplatin resistance in NPC-SP cells.
Conclusion
Exosomes loaded with circPARD3 promoted EBV-miR-BART4-induced stemness and cisplatin resistance in NPC-SP cells through the miR-579-3p/SIRT1/SSRP1 axis.
Graphical abstract
Similar content being viewed by others
Data availability
The datasets used or analyzed during the current study are available from the corresponding author on reasonable request.
Code availability
Not applicable.
References
Ai J, Li W, Zeng R, Xie Z, Liu H, Hou M, Tan G. Blockage of SSRP1/Ets-1/Pim-3 signalling enhances chemosensitivity of nasopharyngeal carcinoma to docetaxel in vitro. Biomed Pharmacother. 2016;83:1022–31.
Alves-Fernandes DK, Jasiulionis MG. The role of SIRT1 on DNA damage response and epigenetic alterations in cancer. Int J Mol Sci. 2019;20(13).
Bi L, Xie C, Jiao L, Jin S, Hnit SST, Mu Y, Wang Y, et al. CPF impedes cell cycle re-entry of quiescent lung cancer cells through transcriptional suppression of FACT and c-MYC. J Cell Mol Med. 2020;24(3):2229–39.
Bissey PA, Teng M, Law JH, Shi W, Bruce JP, Petit V, Tsao SW, et al. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma. BMC Cancer. 2020;20(1):597.
Cai L, Long Y, Chong T, Cai W, Tsang CM, Zhou X, Lin Y, et al. EBV-miR-BART7-3p imposes stemness in nasopharyngeal carcinoma cells by suppressing SMAD7. Front Genet. 2019;10:939.
Calvanese V, Fraga MF. SirT1 brings stemness closer to cancer and aging. Aging (albany NY). 2011;3(2):162–7.
Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64–80.
Du T, Jiang J, Chen Y, Zhang N, Chen G, Wang X, Long X, et al. MiR-138-1-3p alters the stemness and radiosensitivity of tumor cells by targeting CRIPTO and the JAK2/STAT3 pathway in nasopharyngeal carcinoma. Ann Transl Med. 2021;9(6):485.
Ehteda A, Simon S, Franshaw L, Giorgi FM, Liu J, Joshi S, Rouaen JRC, et al. Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG. Cell Rep. 2021;35(2):108994.
Ellsworth RE, Blackburn HL, Shriver CD, Soon-Shiong P, Ellsworth DL. Molecular heterogeneity in breast cancer: State of the science and implications for patient care. Semin Cell Dev Biol. 2017;64:65–72.
Fattore L, Mancini R, Acunzo M, Romano G, Lagana A, Pisanu ME, Malpicci D, et al. miR-579-3p controls melanoma progression and resistance to target therapy. Proc Natl Acad Sci U S A. 2016;113(34):E5005-5013.
Gao W, Guo H, Niu M, Zheng X, Zhang Y, Xue X, Bo Y, et al. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway. Mol Cancer. 2020;19(1):166.
He S, Wang Z, Tang H, Dong J, Qu Y, Lv J. MiR-217 Inhibits Proliferation, Migration, and Invasion by Targeting SIRT1 in Osteosarcoma. Cancer Biother Radiopharm. 2019;34(4):264–70.
Jiang Q, Zhou Y, Yang H, Li L, Deng X, Cheng C, Xie Y, et al. A directly negative interaction of miR-203 and ZEB2 modulates tumor stemness and chemotherapy resistance in nasopharyngeal carcinoma. Oncotarget. 2016;7(41):67288–301.
Jiang S, Huang C, Zheng G, Yi W, Wu B, Tang J, Liu X, et al. EGCG inhibits proliferation and induces apoptosis through downregulation of SIRT1 in nasopharyngeal carcinoma cells. Front Nutr. 2022;9: 851972.
Lam WKJ, Chan JYK. Recent advances in the management of nasopharyngeal carcinoma. F1000Res. 2018;7.
Li Y, Chen B, Huang S. Identification of circRNAs for miRNA targets by Argonaute2 RNA immunoprecipitation and luciferase screening assays. Methods Mol Biol. 2018;1724:209–18.
Lin DC, Meng X, Hazawa M, Nagata Y, Varela AM, Xu L, Sato Y, et al. The genomic landscape of nasopharyngeal carcinoma. Nat Genet. 2014;46(8):866–71.
Liu L, Liu C, Zhang Q, Shen J, Zhang H, Shan J, Duan G, et al. SIRT1-mediated transcriptional regulation of SOX2 is important for self-renewal of liver cancer stem cells. Hepatology. 2016;64(3):814–27.
Liu Y, Jiang Q, Liu X, Lin X, Tang Z, Liu C, Zhou J, et al. Cinobufotalin powerfully reversed EBV-miR-BART22-induced cisplatin resistance via stimulating MAP2K4 to antagonize non-muscle myosin heavy chain IIA/glycogen synthase 3beta/beta-catenin signaling pathway. EBioMedicine. 2019;48:386–404.
Nath M, Roy D, Choudhury Y. Circular RNAs are potential prognostic markers of head and neck squamous cell carcinoma: findings of a meta-analysis study. Front Oncol. 2022;12:782439.
Su M, Xiao Y, Ma J, Tang Y, Tian B, Zhang Y, Li X, et al. Circular RNAs in Cancer: emerging functions in hallmarks, stemness, resistance and roles as potential biomarkers. Mol Cancer. 2019;18(1):90.
Tsao SW, Tsang CM, Lo KW. Epstein-Barr virus infection and nasopharyngeal carcinoma. Philos Trans R Soc Lond B Biol Sci. 2017;372(1732):20160270.
Wu Q, Han T, Sheng X, Zhang N, Wang P. Downregulation of EB virus miR-BART4 inhibits proliferation and aggressiveness while promoting radiosensitivity of nasopharyngeal carcinoma. Biomed Pharmacother. 2018;108:741–51.
Wu RR, Zhong Q, Liu HF, Liu SB. Role of miR-579-3p in the development of squamous cell lung carcinoma and the regulatory mechanisms. Eur Rev Med Pharmacol Sci. 2019;23(21):9464–70.
Xiao Z, Chen Z. Deciphering nasopharyngeal carcinoma pathogenesis via proteomics. Expert Rev Proteomics. 2019;16(6):475–85.
Xu Y, Wang Q, Li X, Chen Y, Xu G. Itraconazole attenuates the stemness of nasopharyngeal carcinoma cells via triggering ferroptosis. Environ Toxicol. 2021;36(2):257–66.
Ye Y, Zhou Y, Zhang L, Chen Y, Lyu X, Cai L, Lu Y, et al. EBV-miR-BART1 is involved in regulating metabolism-associated genes in nasopharyngeal carcinoma. Biochem Biophys Res Commun. 2013;436(1):19–24.
Yousafzai NA, Jin H, Ullah M, Wang X. Recent advances of SIRT1 and implications in chemotherapeutics resistance in cancer. Am J Cancer Res. 2021;11(11):5233–48.
Zeng Z, Zhao Y, Chen Q, Zhu S, Niu Y, Ye Z, Hu P, et al. Hypoxic exosomal HIF-1alpha-stabilizing circZNF91 promotes chemoresistance of normoxic pancreatic cancer cells via enhancing glycolysis. Oncogene. 2021;40(36):5505–17.
Zhang T, Kraus WL. SIRT1-dependent regulation of chromatin and transcription: linking NAD(+) metabolism and signaling to the control of cellular functions. Biochim Biophys Acta. 2010;1804(8):1666–75.
Zhang M, Zhang Q, Hu Y, Xu L, Jiang Y, Zhang C, Ding L, et al. miR-181a increases FoxO1 acetylation and promotes granulosa cell apoptosis via SIRT1 downregulation. Cell Death Dis. 2017;8(10):e3088.
Funding
Thanks for the grants from the National Natural Science Foundations of China to Jingang Ai (No. 81902785) and the Natural Science Foundations of Hunan Province to Jingang Ai (No. 2021JJ40913).
Author information
Authors and Affiliations
Contributions
AJG and GY conceived the ideas. AJG and GY designed the experiments. AJG and ZZ performed the experiments. AJG and TGL analyzed the data. LW and ZGH provided critical materials. LHH and LTQ wrote the manuscript. AJG supervised the study. All the authors have read and approved the final version for publication.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
Informed written consent from the patients and approval from the Ethics Committee of The Third Xiangya Hospital had been obtained before the collection of clinical tissues. Animal experiments were approved by the Animal Research Ethics Committee of The Third Xiangya Hospital and performed per the guidelines of the Ministry of Science and Technology of the People's Republic of China.
Consent for publication
Informed written consent from the patients and approval from the Ethics Committee of The Third Xiangya Hospital had been obtained before the collection of clinical tissues.
Conflicts of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Ai, J., Tan, G., Li, W. et al. Exosomes loaded with circPARD3 promotes EBV-miR-BART4-induced stemness and cisplatin resistance in nasopharyngeal carcinoma side population cells through the miR-579-3p/SIRT1/SSRP1 axis. Cell Biol Toxicol 39, 537–556 (2023). https://doi.org/10.1007/s10565-022-09738-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10565-022-09738-w